dr. singal on the fda approval of cabozantinib in hcc
Published 5 years ago • 216 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
1:18
dr. abou-alfa on the fda approval of cabozantinib in hcc
-
5:31
fda d.i.s.c.o.: fda approval of cabozantinib for hepatocellular carcinoma
-
1:06
dr. choueiri on fda approval of cabozantinib for rcc
-
6:39
emerging second-line therapies in hcc
-
15:26
perspectives on the future treatment of hcc
-
2:45
sequencing with cabozantinib in advanced hcc
-
2:33
celestial trial: second-line cabozantinib’s value in hcc
-
2:09
comparing afami-cel with existing treatments in synovial sarcoma
-
1:22
copy of dr. mcgregor on implications of the fda approval of pembrolizumab/axitinib in rcc
-
6:03
considerations for biopsy in diagnosing hcc
-
3:15
advances in systemic therapy for hcc
-
5:31
newly diagnosed metastatic renal cell carcinoma
-
6:54
diagnostic workup for hcc
-
0:51
dr. pal on the rationale for adding cabozantinib to atezolizumab in prostate cancer
-
0:57
fda approves cabozantinib for advanced rcc
-
1:16
dr. mcgregor on combination therapies with nivolumab, cabozantinib, and sunitinib in rcc
-
0:37
dr. rischin on the fda approval of cemiplimab for cscc
-
3:16
cabosun: upfront use of cabozantinib for mrcc
-
9:48
emerging novel combinations in advanced hcc